Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Editas Medicine (EDIT) over the last 3 years, with Sep 2025 value amounting to $62,000.

  • Editas Medicine's Amortizatization of Intangibles fell 95.32% to $62,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 74.79%. This contributed to the annual value of $5.8 million for FY2024, which is 20.07% up from last year.
  • Editas Medicine's Amortizatization of Intangibles amounted to $62,000 in Q3 2025, which was down 75.88% from $257,000 recorded in Q2 2025.
  • Over the past 5 years, Editas Medicine's Amortizatization of Intangibles peaked at $2.1 million during Q4 2023, and registered a low of $62,000 during Q3 2025.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $869,000 (2024), whereas its average is $1.0 million.
  • In the last 5 years, Editas Medicine's Amortizatization of Intangibles spiked by 322.29% in 2023 and then plummeted by 95.32% in 2025.
  • Over the past 4 years, Editas Medicine's Amortizatization of Intangibles (Quarterly) stood at $498,000 in 2022, then spiked by 322.29% to $2.1 million in 2023, then slumped by 58.68% to $869,000 in 2024, then slumped by 95.32% to $62,000 in 2025.
  • Its Amortizatization of Intangibles was $62,000 in Q3 2025, compared to $257,000 in Q2 2025 and $583,000 in Q1 2025.